HealthTech.euabout 1 hour ago
Switchpoint Bio Raises $5.3M for AI Epigenomics
4 min read
Helsinki-Cambridge biotech startup Switchpoint Bio raised $5.3 million in a pre-seed financing round, including a $5 million investment from Treehouse Delmar Investments. The company combines precision epigenomic profiling and AI to measure how disease and treatment change human biology from routine blood samples. Funds support clinical validation in autoimmune disease and expansion of datasets.
Level
Hype check
Tap to vote and see what everyone thinks.
